| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |